FDA approves cabotegravir LA; New HIV PrEP option fills an important gapDecember 21, 2021HIVInfectious Diseases
COVID-19 asymptomatic infection rate remains highDecember 15, 2021COVID-19 UpdatesInfectious Diseases
Risk for severe COVID-19 and death plummets with Pfizer boosterDecember 9, 2021COVID-19 UpdatesPulmonologyInfectious DiseasesVaccines
New HIV PrEP guidelines call for clinicians to talk to patients about HIV prevention medsDecember 9, 2021Infectious DiseasesHIVHealth Policy
New data on rare myocarditis after COVID-19 vaccinationDecember 8, 2021COVID-19 UpdatesCardiologyInfectious Diseases
FDA approves first drug for treatment of resistant cytomegalovirus infectionNovember 29, 2021Infectious DiseasesMixed Topics
Big drop in U.S. cervical cancer rates, mortality in younger womenNovember 29, 2021Women's HealthVaccinesOncologyInfectious Diseases
HCV screening in pregnancy: Reducing the risk for casualties in the quest for eliminationNovember 23, 2021Women's HealthInfectious DiseasesHepatitis
HIV services are bouncing back from COVID-19 disruptions, data suggest, but recovery is ‘precarious’November 22, 2021Infectious DiseasesCOVID-19 UpdatesHIV
FDA authorizes COVID boosters for all U.S. adultsNovember 19, 2021COVID-19 UpdatesInfectious DiseasesPulmonologyVaccines
Mask-wearing cuts new COVID-19 cases by 53%, study saysNovember 19, 2021COVID-19 UpdatesInfectious DiseasesPulmonologyHealth Policy
Should you worry about picking up COVID or other infections from public bathrooms?November 18, 2021Infectious DiseasesCOVID-19 Updates
More than half of people living with HIV have coronary plaqueNovember 8, 2021HIVCardiologyInfectious Diseases
